An article in The Journal For Nurse Practitioners found that Depo-Testosterone was the most cost-efficient TRT option, and ...

Hims & Hers Health recurring revenue grew 111% YoY, boosted by personalization and chronic care. Forecasting $2.35B revenue ...

The APAC region leads with over 45% market share, driven by natural ingredient preferences. Offline sales dominate, but e-commerce continues to expan ...

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that ...

Breast cancer, affecting both women and men, often begins subtly, making early detection crucial for successful treatment. Recognizing signs like pers ...

Colorectal cancer is a significant global health concern, with rising cases, especially among younger individuals. Early ...

Dr. Sharon Malone, OBGYN and chief medical advisor for Alloy Health, joins TODAY’s Jenna Bush Hager and guest co-host Ciara ...